Messenger Biopharma will not develop its own mRNA products and will not produce mRNA.

We are eager to out-license our technologies to pharmaceutical companies for the development of mRNA vaccines and therapies, and to CDMOs for the production of mRNA using at least one of our technologies.

Last news


Réseau Entreprendre Auvergne has rewarded twenty projects of creation or…

posted June 20, 2016

“Réseau Entreprendre Auvergne has rewarded ...Read More